Beth Braddock, FNP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 15116 Gibson Rd, Ashville, OH 43103 Phone: 740-804-2756 |
Margaret L Barrows, CNP Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 17902 Winchester Rd, Ashville, OH 43103 Phone: 614-202-4854 |
Meghan Yahn, MSN, APRN, FNP-C Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 299 Main St W, Ashville, OH 43103 Phone: 740-983-8594 Fax: 740-983-3340 |
Mr. Gary Artrip, CNP Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 9199 Hagerty Rd, Ashville, OH 43103 Phone: 740-477-8113 |
Mr. Michael Steven Mann Ii, CNP Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 3175 Clifford Ave, Ashville, OH 43103 Phone: 740-248-6505 |
News Archive
Stretch sensors in our muscles participate in reflexes that serve the subconscious control of posture and movement. According to a new study published in the Journal of Neuroscience, these sensors respond weakly to muscle stretch caused by one's voluntary action, and most strongly to stretch that is imposed by external forces. The ability to reflect causality in this manner can facilitate appropriate reflex control and accurate self-perception.
Blood levels of a protein that helps regulate inflammation may also serve as a red flag for relapse in some schizophrenia patients, researchers said.
Harvard Bioscience, Inc. a global developer, manufacturer, and marketer of a broad range of tools to advance life science research and regenerative medicine, today reported unaudited financial highlights for the three and nine months ended September 30, 2010.
RBC Life Sciences, Inc., a provider of proprietary nutritional supplements, and wound care and pain management products, today reported consolidated net sales of $28.4 million for the year ended December 31, 2011, a 1% increase over 2010 consolidated net sales of $28.2 million.
Arno Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing oncology therapeutics, today announced that it has closed a private placement of its securities resulting in gross proceeds to the company of over $15 million.
› Verified 7 days ago